Published in Trans R Soc Trop Med Hyg on January 01, 1985
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A (2012) 3.35
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol (2009) 1.45
Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol (2000) 1.24
Pathogenesis of Lassa fever. Viruses (2012) 1.23
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers. Virology (2007) 1.02
Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol (2009) 0.97
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. PLoS Pathog (2015) 0.96
Progress in the experimental therapy of severe arenaviral infections. Future Microbiol (2011) 0.90
Progress towards recombinant anti-infective antibodies. Recent Pat Antiinfect Drug Discov (2009) 0.88
Immune responses and Lassa virus infection. Viruses (2012) 0.86
Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol (2013) 0.85
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res (2016) 0.83
Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever. PLoS Pathog (2016) 0.77
How to approach and treat viral infections in ICU patients. BMC Infect Dis (2014) 0.77
Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus (2015) 0.75
Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria. Niger Med J (2016) 0.75
Native functionality and therapeutic targeting of arenaviral glycoproteins. Curr Opin Virol (2016) 0.75
Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques. J Virol (2014) 0.75
Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol (2015) 0.75
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg (1970) 4.96
Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 4.67
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis (1999) 3.47
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol (2004) 2.72
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl (1996) 2.63
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest (2000) 2.45
Differentiation of filoviruses by electron microscopy. Virus Res (1995) 2.39
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest (2001) 2.38
Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med (1996) 2.23
Reconstructive surgery with a dermal regeneration template: clinical and histologic study. Plast Reconstr Surg (2001) 2.02
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine (2000) 1.95
Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol (1987) 1.83
Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J Comp Pathol (1992) 1.78
Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch Pathol Lab Med (1992) 1.71
The toxic shock syndrome in burned children. Burns Incl Therm Inj (1985) 1.61
Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med (1997) 1.61
Lassa fever. Virological and serological studies. Trans R Soc Trop Med Hyg (1972) 1.60
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis (1989) 1.58
Strengthening national preparedness for smallpox: an update. Emerg Infect Dis (2001) 1.52
Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun (1981) 1.51
Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun (1982) 1.47
Immunohistochemical analysis of burn depth. J Burn Care Rehabil (1999) 1.46
Malignant melanoma disguised by a tattoo. Br J Plast Surg (1999) 1.44
Silicone breast implants: complications. Br J Plast Surg (1997) 1.39
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A (1991) 1.37
Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect Immun (1984) 1.36
Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab Anim Sci (1992) 1.36
Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett (2001) 1.32
The use of Lassa fever convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg (1984) 1.31
Medical problems of American children living overseas. Pediatr Clin North Am (1970) 1.31
Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J Infect Dis (1984) 1.30
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29
Surveillance of Lassa fever in missionaries stationed in West Africa. Bull World Health Organ (1975) 1.27
Analysis of the monkeypox virus genome. Virology (2002) 1.27
Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters. Infect Immun (1973) 1.26
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A. Vaccine (1999) 1.25
Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells. J Infect Dis (1975) 1.24
Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg (1994) 1.21
NIH funding and biomedical publication output. Fed Proc (1976) 1.20
Observations of equines, humans and domestic and wild vertebrates during the 1969 equine epizootic and epidemic of Venezuelan encephalitis in Guatemala. Am J Epidemiol (1972) 1.18
Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses. Am J Pathol (1973) 1.18
Correlates to increased lethality of attenuated Venezuelan encephalitis virus vaccine for immunosuppressed hamsters. Infect Immun (1974) 1.18
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17
Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic. J Clin Pathol (1990) 1.17
Filovirus contamination of cell cultures. Dev Biol Stand (1992) 1.17
Pyoderma gangrenosum following breast reconstruction. Br J Plast Surg (2000) 1.13
Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment. Trop Med Parasitol (1991) 1.12
Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody. Lancet (1985) 1.12
Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol (1984) 1.11
The potential of 5' nuclease PCR for detecting a single-base polymorphism in Orthopoxvirus. Mol Cell Probes (1997) 1.10
Real-time microchip PCR for detecting single-base differences in viral and human DNA. Anal Chem (1998) 1.08
Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters. Arch Virol (1976) 1.07
Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg (1987) 1.07
Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever. Am J Trop Med Hyg (1994) 1.06
Patients infected with high-hazard viruses: scientific basis for infection control. Arch Virol Suppl (1996) 1.06
Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVSMM/PBj) isolate from sooty mangabeys. AIDS Res Hum Retroviruses (1992) 1.03
Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans R Soc Trop Med Hyg (1984) 1.03
Pathology of Lassa virus infection in the rhesus monkey. Am J Trop Med Hyg (1982) 1.02
Skin graft storage and keratinocyte viability. Br J Plast Surg (1993) 1.02
Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin. J Med Virol (1983) 1.01
Replication of hemorrhagic fever viruses in monocytic cells. Rev Infect Dis (1989) 1.00
Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population. J Gen Virol (1976) 1.00
Experimental Lassa fever virus infection successfully treated with ribavirin. Lancet (1979) 0.99
Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine. Infect Immun (1973) 0.98
Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia. Trans R Soc Trop Med Hyg (1984) 0.98
Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 0.97
Can protracted relapsing fever resemble Lyme disease? Med Hypotheses (1991) 0.97
Chromatographic separations of alphavirus strains by hydroxylapatite. J Clin Microbiol (1977) 0.96
Molecular characterization and comparison of simian immunodeficiency virus isolates from macaques, mangabeys, and African green monkeys. J Med Primatol (1989) 0.96
Marburg virus vaccines: comparing classical and new approaches. Vaccine (2001) 0.95
Renal transplant-associated malaria. JAMA (1980) 0.95
Differential alterations in host peripheral polymorphonuclear leukocyte chemiluminescence during the course of bacterial and viral infections. Infect Immun (1980) 0.95
Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. J Infect Dis (1977) 0.94
Virus-initiated septic shock. Acute death of Venezuelan encephalitis virus-infected hamsters. Lab Invest (1975) 0.94
Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin Exp Immunol (1980) 0.93
In vitro characterization of an artificial dermal scaffold. Tissue Eng (2001) 0.93
Lightning: the multisystem group injuries. J Trauma (1999) 0.92
An outbreak of antibiotic-resistant Salmonella enteritidis in Liberia, West Africa. J Infect Dis (1985) 0.91
Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab Anim Sci (1994) 0.91
Immune serum increases arenavirus replication in monocytes. J Gen Virol (1988) 0.90
A system for making hospital solutions in the Third World. Trop Doct (1988) 0.90
High incidence of viral hepatitis among American missionaries in Africa. Am J Trop Med Hyg (1990) 0.90
Ecologic studies of Venezuelan encephalitis virus and isolations of Nepuyo and Patois viruses during 1968-1973 at a marsh habitat near the epicenter of the 1969 outbreak in Guatemala. Am J Trop Med Hyg (1976) 0.89
A probable endocrine basis for the depression of ketone bodies during infectious or inflammatory state in rats. Endocrinology (1980) 0.89
Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). Am J Trop Med Hyg (1996) 0.88
Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med Microbiol Immunol (1986) 0.88
Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. Microb Pathog (1990) 0.88